Background Compromised neurocognition is a core feature of schizophrenia. With increasing studies researching cognitive function of Chinese patients with first-episode schizophrenia (FES) using MATRICS Consensus Cogni...Background Compromised neurocognition is a core feature of schizophrenia. With increasing studies researching cognitive function of Chinese patients with first-episode schizophrenia (FES) using MATRICS Consensus Cognitive Battery (MCCB), it is not clear about the level and pattern of cognitive impairment among this population. Aim To provide a meta-analysis systematically analysing studies of neurocognitive function using MCCB in Chinese patients with FES. Methods An independent literature search of both Chinese and English databases up to 13 March 2019 was conducted by two reviewers. Standardised mean difference (SMD) was calculated using the random effects model to evaluate the effect size. Results 56 studies (FES=3167, healthy controls (HC)=3017) were included and analysed. No study was rated as 'high quality' according to Strengthening the Reporting of Observational Studies in Epidemiology. Compared with HCs, Chinese patients with FES showed impairment with large effect size in overall cognition (SMD=-1.60,95% Cl -1.82 to -1.38,厂=67%) and all seven cognitive domains, with the SMD ranging from -0.87 to -1.41. In nine MCCB subtests, patients with FES showed significant difference in Symbol Coding (SMD=-1.90), Trail Making Test (TMT)(SMD=-1.36), Continuous Performance Test-Identical Pairs (SMD=-1.33), Hopkins Verbal Learning Test (SMD=-1.24), Brief Visuospatial Memory Test (SMD=-1.18), Mazes (SMD=-1.16), Category Fluency (SMD=-1.01), Spatial Span (SMD=-0.69) and Mayer-Salovey-Caruso Emotional Intelligence Test (SMD=-0.38). Conclusions Our meta-analysis demonstrates that Chinese patients with FES show neurocognitive deficits across all seven MCCB cognitive domains and all nine subtests, particularly in two neurocognitive domains: speed of processing and attention/vigilance, with the least impairment shown in social cognition. Symbol Coding and TMT may be the most sensitive tests to detect cognitive deficit in Chinese patients with FES.展开更多
BACKGROUND The efficacy of cognitive behavioral group therapy(CBGT)for cognitive dysfunction and negative symptoms of schizophrenia is established,but more evidence is required.AIM To assess the effectiveness of CBGT ...BACKGROUND The efficacy of cognitive behavioral group therapy(CBGT)for cognitive dysfunction and negative symptoms of schizophrenia is established,but more evidence is required.AIM To assess the effectiveness of CBGT combined with mental health education as a treatment for schizophrenia compared with mental health education alone.METHODS In all,120 schizophrenia out-patients were randomized into CBGT combined with mental health education or single mental health education.The primary outcomes were positive and negative symptoms,cognitive function,excitatory factor,anxiety and depression symptom improvements on the positive and negative syndrome scale score.Secondary outcome measures included social function and drug compliance.RESULTS There were significant differences between CBGT combined with mental health education and single mental health education on measures of positive and negative symptoms,cognitive functions,excitatory factor,anxiety and depression symptoms,and social functions.No other significant difference in outcomes was observed.CONCLUSION CBGT combined with mental health education may be relevant beneficial treatment method in reducing symptoms,cognitive and social functions of patients with schizophrenia.展开更多
目的探讨首发家族性与散发性精神分裂症患者的认知功能差异。方法纳入首发精神分裂症患者127例,其中家族性患者40例,散发性患者87例;同时纳入96名正常对照。采用修订的韦氏成人智力测验中部分量表对所有受试者进行认知功能评估,阳性与...目的探讨首发家族性与散发性精神分裂症患者的认知功能差异。方法纳入首发精神分裂症患者127例,其中家族性患者40例,散发性患者87例;同时纳入96名正常对照。采用修订的韦氏成人智力测验中部分量表对所有受试者进行认知功能评估,阳性与阴性症状量表(positive and negative syndrome scale,PANSS)评定患者症状的严重程度,并分析认知功能与精神症状的相关性。结果家族性组与散发性组患者PANSS总分[(91.51±14.07)vs.(87.23±16.37)]、阳性症状分[(25.89±6.70)vs.(23.72±6.04)]、阴性症状分[(18.19±6.43)vs.(19.07±8.01)]差异无统计学意义(P>0.05);两患者组全智商量表分、言语智商量表分和操作智商量表分均低于对照组(均P<0.05),散发性组操作智商量表分低于家族性组(P<0.05)。散发性组患者操作智商与PANSS总分(r=-0.46,P﹤0.01)、阳性症状分(r=-0.41,P=0.01)及阴性症状分(r=-0.36,P=0.02)呈负相关;木块图形校正分与PANSS总分(r=-0.41,P=0.01)及阳性症状分(r=-0.54,P<0.01)呈负相关。而家族性组中无此相关关系(均P>0.05)。结论首发精神分裂患者在发病初期认知功能即存在显著损害,散发性患者在智力方面受损较重,其受损程度与临床症状严重程度相关,而家族性患者智力的损害则独立于临床症状。展开更多
目的探讨系统家庭治疗对慢性精神分裂症患者认知功能的影响。方法将73例慢性精神分裂症患者随机分为两组,均服用利培酮维持治疗,干预组使用药物治疗的同时合并系统家庭治疗,对照组单纯使用药物治疗。观察疗程为24个月,于入组时及24个月...目的探讨系统家庭治疗对慢性精神分裂症患者认知功能的影响。方法将73例慢性精神分裂症患者随机分为两组,均服用利培酮维持治疗,干预组使用药物治疗的同时合并系统家庭治疗,对照组单纯使用药物治疗。观察疗程为24个月,于入组时及24个月后采用阳性与阴性症状量表（PAN SS）评定患者的临床疗效,同时给予威斯康星卡片分类测验（W CST）和连续作业测验（CPT）评定患者的认知功能。结果 PAN SS总评分在入组时及24个月后两组之间无统计学差异（t=1.253,1.725,P均〉0.05）,但干预组各项认知功能指标均较对照组有不同程度的改善（t=2.472~4.783,P〈0.05或P〈0.01）。结论系统家庭治疗能有效改善慢性精神分裂症患者的认知功能。展开更多
文摘Background Compromised neurocognition is a core feature of schizophrenia. With increasing studies researching cognitive function of Chinese patients with first-episode schizophrenia (FES) using MATRICS Consensus Cognitive Battery (MCCB), it is not clear about the level and pattern of cognitive impairment among this population. Aim To provide a meta-analysis systematically analysing studies of neurocognitive function using MCCB in Chinese patients with FES. Methods An independent literature search of both Chinese and English databases up to 13 March 2019 was conducted by two reviewers. Standardised mean difference (SMD) was calculated using the random effects model to evaluate the effect size. Results 56 studies (FES=3167, healthy controls (HC)=3017) were included and analysed. No study was rated as 'high quality' according to Strengthening the Reporting of Observational Studies in Epidemiology. Compared with HCs, Chinese patients with FES showed impairment with large effect size in overall cognition (SMD=-1.60,95% Cl -1.82 to -1.38,厂=67%) and all seven cognitive domains, with the SMD ranging from -0.87 to -1.41. In nine MCCB subtests, patients with FES showed significant difference in Symbol Coding (SMD=-1.90), Trail Making Test (TMT)(SMD=-1.36), Continuous Performance Test-Identical Pairs (SMD=-1.33), Hopkins Verbal Learning Test (SMD=-1.24), Brief Visuospatial Memory Test (SMD=-1.18), Mazes (SMD=-1.16), Category Fluency (SMD=-1.01), Spatial Span (SMD=-0.69) and Mayer-Salovey-Caruso Emotional Intelligence Test (SMD=-0.38). Conclusions Our meta-analysis demonstrates that Chinese patients with FES show neurocognitive deficits across all seven MCCB cognitive domains and all nine subtests, particularly in two neurocognitive domains: speed of processing and attention/vigilance, with the least impairment shown in social cognition. Symbol Coding and TMT may be the most sensitive tests to detect cognitive deficit in Chinese patients with FES.
基金Supported by Science and Technology Innovation Bureau,Longhua District,Shenzhen,Guangdong Province,China,No.2020202.
文摘BACKGROUND The efficacy of cognitive behavioral group therapy(CBGT)for cognitive dysfunction and negative symptoms of schizophrenia is established,but more evidence is required.AIM To assess the effectiveness of CBGT combined with mental health education as a treatment for schizophrenia compared with mental health education alone.METHODS In all,120 schizophrenia out-patients were randomized into CBGT combined with mental health education or single mental health education.The primary outcomes were positive and negative symptoms,cognitive function,excitatory factor,anxiety and depression symptom improvements on the positive and negative syndrome scale score.Secondary outcome measures included social function and drug compliance.RESULTS There were significant differences between CBGT combined with mental health education and single mental health education on measures of positive and negative symptoms,cognitive functions,excitatory factor,anxiety and depression symptoms,and social functions.No other significant difference in outcomes was observed.CONCLUSION CBGT combined with mental health education may be relevant beneficial treatment method in reducing symptoms,cognitive and social functions of patients with schizophrenia.
文摘目的探讨首发家族性与散发性精神分裂症患者的认知功能差异。方法纳入首发精神分裂症患者127例,其中家族性患者40例,散发性患者87例;同时纳入96名正常对照。采用修订的韦氏成人智力测验中部分量表对所有受试者进行认知功能评估,阳性与阴性症状量表(positive and negative syndrome scale,PANSS)评定患者症状的严重程度,并分析认知功能与精神症状的相关性。结果家族性组与散发性组患者PANSS总分[(91.51±14.07)vs.(87.23±16.37)]、阳性症状分[(25.89±6.70)vs.(23.72±6.04)]、阴性症状分[(18.19±6.43)vs.(19.07±8.01)]差异无统计学意义(P>0.05);两患者组全智商量表分、言语智商量表分和操作智商量表分均低于对照组(均P<0.05),散发性组操作智商量表分低于家族性组(P<0.05)。散发性组患者操作智商与PANSS总分(r=-0.46,P﹤0.01)、阳性症状分(r=-0.41,P=0.01)及阴性症状分(r=-0.36,P=0.02)呈负相关;木块图形校正分与PANSS总分(r=-0.41,P=0.01)及阳性症状分(r=-0.54,P<0.01)呈负相关。而家族性组中无此相关关系(均P>0.05)。结论首发精神分裂患者在发病初期认知功能即存在显著损害,散发性患者在智力方面受损较重,其受损程度与临床症状严重程度相关,而家族性患者智力的损害则独立于临床症状。
文摘目的探讨系统家庭治疗对慢性精神分裂症患者认知功能的影响。方法将73例慢性精神分裂症患者随机分为两组,均服用利培酮维持治疗,干预组使用药物治疗的同时合并系统家庭治疗,对照组单纯使用药物治疗。观察疗程为24个月,于入组时及24个月后采用阳性与阴性症状量表（PAN SS）评定患者的临床疗效,同时给予威斯康星卡片分类测验（W CST）和连续作业测验（CPT）评定患者的认知功能。结果 PAN SS总评分在入组时及24个月后两组之间无统计学差异（t=1.253,1.725,P均〉0.05）,但干预组各项认知功能指标均较对照组有不同程度的改善（t=2.472~4.783,P〈0.05或P〈0.01）。结论系统家庭治疗能有效改善慢性精神分裂症患者的认知功能。
